The overall goals of this proposal are to address issues (particularly in elderly patients) concerning the clinical toxicology of drugs that represent one of the most frequently prescribed group of agents. Literally millions of patients each day take the drugs we propose to study. New data, largely generated from our laboratory, have identified unique metabolic pathways, namely chiral inversion and futile cycling, that may have important toxicological ramifications. The general aim of this proposal is to better understand the mechanisms of these pathways, to quantify them in relevant patient groups and to explore their biologic/toxicologic relevance. Through our prior grant support, this laboratory has pursued questions concerning the pharmacokinetics and pharmacodynamics of nonsteroidal anti- inflammatory drugs (NSAIDs). As a logical sequel to prior studies in this area, we propose addressing the following questions relevant to arylpropionic NSAIDs: 1) Does administration of pure S(+)-ibuprofen avoid formation of hybrid triglycerides and phospholipids as occurs with administration of the antipode? In turn, does administration of pure S-ibuprofen avoid persistence of ibuprofen in plasma as occurs with dosing of the racemate? 2) Does formation of hybrid triglycerides result in a decreased ability to hydrolyze the ibuprofen from the glycerol backbone? Does the same apply to hydrolysis by phospholipase A2 of hybrid phospholipids? 3) Does formation of coenzyme A thioesters from ibuprofen result in incorporation of ibuprofen into cell membranes? 4) Does futile cycling of ketoprofen coupled with its chiral inversion result in accumulation of the active S-enantiomer in elderly patients? In turn, does accumulation result in adverse renal effects?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK037994-13
Application #
2734052
Study Section
Special Emphasis Panel (ZRG4-GRM (01))
Program Officer
Scherbenske, M James
Project Start
1986-03-01
Project End
2000-06-30
Budget Start
1998-07-01
Budget End
2000-06-30
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Brater, D Craig (2011) Update in diuretic therapy: clinical pharmacology. Semin Nephrol 31:483-94
Bennett, Susan J; Lane, Kathleen A; Welch, Janet et al. (2005) Medication and dietary compliance beliefs in heart failure. West J Nurs Res 27:977-93; discussion 994-9
Shankar, Sudha S; Brater, D Craig (2003) Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 284:F11-21
Chalasani, N; Gorski, J C; Horlander Sr, J C et al. (2001) Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12:1010-6
Brater, D C; Chalasani, N; Gorski, J C et al. (2001) Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites. Trans Am Clin Climatol Assoc 112:108-15; discussion 116
Bennett, S J; Perkins, S M; Lane, K A et al. (2001) Social support and health-related quality of life in chronic heart failure patients. Qual Life Res 10:671-82
Bennett, S J; Perkins, S M; Lane, K A et al. (2001) Reliability and validity of the compliance belief scales among patients with heart failure. Heart Lung 30:177-85
Masica, A L; Azie, N E; Brater, D C et al. (2000) Intravenous diltiazem and CYP3A-mediated metabolism. Br J Clin Pharmacol 50:273-6
Agarwal, R; Gorski, J C; Sundblad, K et al. (2000) Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. J Am Soc Nephrol 11:1100-5
Grubb, N G; Rudy, D W; Brater, D C et al. (1999) Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination. Br J Clin Pharmacol 48:494-500

Showing the most recent 10 out of 37 publications